Clascoterone Cream (Winlevi) for Acne
Date: December 27, 2021 Issue #: 1640 Summary: The FDA has approved Winlevi (Sun), a 1% cream formulation of the androgen receptor inhibitor clascoterone, for treatment of acne vulgaris in patients ≥12 years old. It is the first topical androgen receptor inhibitor to be approved by the FDA.